CLDN4 and ovarian carcinoma: Lin et al. have showed that absence of claudin-3 and claudin-4 enhanced the EMT activity in ovarian cancer cells through downregulating E-cadherin expression, upregulating Twist, and activating the PI3K pathway (Lin et al., 2013).